Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chemotherapy Induced Anaemia”

66 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 66 results

Testing effectiveness (Phase 2)Study completedNCT05963334
What this trial is testing

Comparison of Weekly Versus Every Three Weeks of Carboplatin Plus Paclitaxel in Patients With Advanced Epithelial Ovarian Cancer

Who this might be right for
Advanced Epithelial Ovarian Cancer
Cairo University 49
Large-scale testing (Phase 3)Study completedNCT05301517
What this trial is testing

Evaluate the Efficacy and Safety of Roxadustat for the Treatment of Anemia in Participants Receiving Chemotherapy Treatment for Non-Myeloid Malignancies

Who this might be right for
Chemotherapy Induced Anemia
Kyntra Bio 159
Early research (Phase 1)Study completedNCT00080925
What this trial is testing

T-Cell-Depleted Allogeneic Stem Cell Transplantation After Immunoablative Induction Chemotherapy and Reduced-Intensity Transplantation Conditioning in Treating Patients With Hematologic Malignancies

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+3 more
National Institutes of Health Clinical Center (CC) 20
Large-scale testing (Phase 3)Study completedNCT00110955
What this trial is testing

Treatment of Anemia in Subjects With Non-Myeloid Malignancy Receiving Multicycle Chemotherapy

Who this might be right for
AnemiaNon-Myeloid Malignancies
Amgen 391
Post-approval studies (Phase 4)Study completedNCT00315484
What this trial is testing

Hematologic Response of Epoetin Alfa (PROCRIT) Versus Darbepoetin Alfa (ARANESP) in Chemotherapy Induced Anemia

Who this might be right for
AnemiaChemotherapy
Ortho Biotech Products, L.P. 358
Testing effectiveness (Phase 2)Ended earlyNCT01284348
What this trial is testing

To Determine Safe and Effective Dose of Sotatercept for the Treatment of Chemotherapy Induced Anemia in Participants With Advanced Non-small Cell Lung Cancer

Who this might be right for
AnemiaCarcinoma, Non-Small-Cell LungCarcinoma, Small-Cell Lung+3 more
Merck Sharp & Dohme LLC 26
Early research (Phase 1)Study completedNCT01280240
What this trial is testing

Pharmacokinetic Study of Iron Isomaltoside 1000 Administered by 250 mg IV Bolus Injection or 500 mg Intravenous Infusion to Patients With Non-hematological Malignancies Associated With Chemotherapy Induced Anaemia

Who this might be right for
Patients With Chemotherapy Induced Anemia (CIA)
Pharmacosmos A/S 11
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06854276
What this trial is testing

Study of SSS06 for Chemotherapy-Induced Anemia in Non-Myeloid Malignancies

Who this might be right for
Chemotherapy-induced AnemiaNon-myeloid Malignancies
Shenyang Sunshine Pharmaceutical Co., LTD. 80
Not applicableStudy completedNCT01807091
What this trial is testing

Outpatient Induction Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome

Who this might be right for
Adult Acute Myeloid LeukemiaAdult Myelodysplastic Syndrome
University of Washington 17
Not applicableStudy completedNCT02140736
What this trial is testing

Epoetin Alfa Biosimilar in the Management of Chemotherapy-Induced Symptomatic Anemia in Haematology and Oncology

Who this might be right for
Chemotherapy-induced Symptomatic AnemiaSolid TumorsMalignant Hemopathies+2 more
Hospira, now a wholly owned subsidiary of Pfizer 2,333
Large-scale testing (Phase 3)Study completedNCT00148421
What this trial is testing

Study for the Treatment of Anemia in Patients With Non-myeloid Malignancies Receiving Multicycle Chemotherapy.

Who this might be right for
Anemia
Amgen
Large-scale testing (Phase 3)UnknownNCT00482716
What this trial is testing

Epoetin Alfa or Epoetin Beta With or Without Iron Infusion in Treating Anemia in Patients With Cancer

Who this might be right for
AnemiaLeukemiaLymphoma+2 more
St. Bartholomew's Hospital 80
Testing effectiveness (Phase 2)Study completedNCT00338416
What this trial is testing

An Efficacy and Safety Study of PROCRIT (Epoetin Alfa) in Cancer Patients Receiving Chemotherapy Every Three Weeks

Who this might be right for
CancerAnemia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 115
Large-scale testing (Phase 3)Ended earlyNCT04607668
What this trial is testing

Trilaciclib, a CDK 4/6 Inhibitor, in Patients Receiving FOLFOXIRI/Bevacizumab for Metastatic Colorectal Cancer (mCRC):

Who this might be right for
Colorectal Cancer MetastaticMyelosuppression-AdultChemotherapeutic Toxicity
G1 Therapeutics, Inc. 326
Early research (Phase 1)Study completedNCT01213979
What this trial is testing

Open-label Pharmacokinetic Study of Iron Isomaltoside 1000 (Monofer®) Administered by 500 mg IV Bolus Injection or 1000 mg Intravenous Infusion to Patients With Non-hematological Malignancies Associated With Chemotherapy Induced Anaemia (CIA)

Who this might be right for
Non-hematological Malignancies
Pharmacosmos A/S 16
Large-scale testing (Phase 3)Study completedNCT00628043
What this trial is testing

Clinical Study of Epoetin Beta to Chemotherapy-Induced Anemia (CIA) Patients

Who this might be right for
Anemia
Chugai Pharmaceutical 160
Not applicableApproved For MarketingNCT04504513
What this trial is testing

Expanded Access to Trilaciclib for Patients Receiving Chemotherapy for Small Cell Lung Cancer

Who this might be right for
Myelosuppression AdultChemotherapeutic ToxicitySmall Cell Lung Cancer
G1 Therapeutics, Inc.
Testing effectiveness (Phase 2)Study completedNCT00239239
What this trial is testing

Fractionated Dosing Study: Study to Evaluate Darbepoetin Alfa for the Treatment of Anemia in Subjects With Non-Myeloid Malignancies

Who this might be right for
Non-Myeloid MalignanciesAnemiaCancer
Amgen 44
Not applicableStudy completedNCT01626547
What this trial is testing

Biosimilar Retacrit™ (Epoetin Zeta) in the Treatment of Chemotherapy-Induced Symptomatic Anaemia in Haematology and Oncology

Who this might be right for
Chemotherapy-induced Symptomatic AnaemiaSolid TumoursMalignant Lymphomas+1 more
Hospira, now a wholly owned subsidiary of Pfizer 291
Testing effectiveness (Phase 2)UnknownNCT02781155
What this trial is testing

Limiting Chemotherapy Side Effects by Using Moxa

Who this might be right for
Breast NeoplasmsColorectal NeoplasmsGenital Neoplasms, Female+1 more
East and North Hertfordshire NHS Trust 25
Load More Results